Clinical Trials Logo

Clinical Trial Summary

This study seeks to evaluate the safety, acceptability and feasibility of an outpatient "day procedure" for medical abortion at 13-18 weeks gestation. The study regimen will consist of a single dose of 200 mg mifepristone to be taken orally either at home or at the hospital, followed approximately 24 - 48 hours later with administration of 400 mcg misoprostol. Repeat doses of 400 mcg (two tablets) of misoprostol will be administered buccally every three hours until the abortion is achieved.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03346629
Study type Interventional
Source Gynuity Health Projects
Contact
Status Completed
Phase Phase 4
Start date December 1, 2017
Completion date December 31, 2018

See also
  Status Clinical Trial Phase
Completed NCT02235155 - Mifepristone and Misoprostol for Midtrimester Termination of Pregnancy in Uzbekistan N/A
Completed NCT03710239 - OPIOID Study - Pain With Osmotic Dilators N/A
Completed NCT05046041 - Assessing Outpatient 'Day Procedure' for Second-trimester Medical Abortion at Two Public Sector Hospitals in Nepal Phase 4
Completed NCT01766388 - Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Armenia N/A